{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:18:29Z","timestamp":1792819109386,"version":"4.5.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>To construct and validate a risk prediction model for the development of peritoneal dialysis-associated peritonitis (PDAP) in patients undergoing peritoneal dialysis (PD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective analysis included patients undergoing PD at the Department of Nephrology, the First Affiliated Hospital of Anhui University of Chinese Medicine, between January 2016 and January 2021. Baseline data were collected. The primary study endpoint was PDAP occurrence. Patients were divided into a training cohort (<jats:italic>n<\/jats:italic>\u2009=\u2009264) and a validation cohort (<jats:italic>n<\/jats:italic>\u2009=\u2009112) for model building and validation. Least Absolute Shrinkage and Selection Operator (LASSO) regression was applied to optimize the screening variables. Predictive models were developed using multifactorial logistic regression analysis with column line plots. Receiver operating characteristic (ROC) curves, calibration curves, and Hosmer-Lemeshow goodness-of-fit tests were used to verify and evaluate the discrimination and calibration of the prediction models. Decision curve analysis (DCA) was used to assess the clinical validity of the prediction models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five potential predictors of PDAP after PD catheterization were screened using LASSO regression analysis, including neutrophil-to-lymphocyte ratio (NLR), serum ALBumin (ALB), uric acid (UA), high sensitivity C-reactive protein (hsCRP), and diabetes mellitus (DM). Predictive models were developed by multi-factor logistic regression analysis and plotted in columns. The area under the ROC curve (AUC) values were 0.891 (95% confidence interval [CI]: 0.829\u20130.844) and 0.882 (95% CI: 0.722\u20130.957) for the training and validation cohorts, respectively. The Hosmer-Lemeshow test showed a good fit (<jats:italic>p<\/jats:italic>\u2009=\u20090.829 for the training cohort; <jats:italic>p<\/jats:italic>\u2009=\u20090.602 for the validation cohort). The DCA curves indicated that the threshold probabilities for the training and validation cohorts were 4\u201364% and 3\u201390%, respectively, predicting a good net gain for the clinical model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NLR, ALB, UA, hsCRP, and DM are independent predictors of PDAP after PD catheterization. The column line graph model constructed based on the abovementioned factors has good discriminatory and calibrating ability and helps to predict the risk of PDAP after PD catheterization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1193754","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:28:03Z","timestamp":1694770083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Construction and validation of a predictive model for the risk of peritoneal dialysis-associated peritonitis after peritoneal dialysis catheterization"],"prefix":"10.3389","volume":"10","author":[{"given":"Rong","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1053\/j.ajkd.2017.10.019","article-title":"Risk predictors and causes of technique failure within the first year of peritoneal dialysis: an Australia and New Zealand dialysis and transplant registry (ANZDATA) study","volume":"72","author":"See","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"ref2","volume-title":"Peritoneal Dialysis","author":"Sachdeva","year":"2022"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.ajkd.2019.09.016","article-title":"Peritoneal dialysis-related infection rates and outcomes: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS)","volume":"76","author":"Perl","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/asn.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal Dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","article-title":"Changes in the worldwide epidemiology of peritoneal dialysis","volume":"13","author":"Li","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"699502","DOI":"10.3389\/fmed.2021.699502","article-title":"Neutrophil-to-lymphocyte ratio and treatment failure in peritoneal dialysis-associated peritonitis","volume":"8","author":"He","year":"2021","journal-title":"Front Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"875154","DOI":"10.3389\/fmed.2022.875154","article-title":"Development and validation of a prediction model for the cure of peritoneal dialysis-associated peritonitis: a multicenter observational study","volume":"9","author":"Meng","year":"2022","journal-title":"Front Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/j.ijid.2009.07.016","article-title":"Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome","volume":"14","author":"Kofteridis","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit Dial Int"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"m441","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/00365513.2020.1847313","article-title":"Development and validation of a laboratory-based risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19","volume":"81","author":"Martin","year":"2021","journal-title":"Scand J Clin Lab Investig"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1080\/00273171.2018.1557034","article-title":"Improving standard error estimates in multistage estimation: a multiple imputation (Mi) based approach","volume":"54","author":"Huang","year":"2019","journal-title":"Multivar Behav Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/s1470-2045(14)71116-7","article-title":"Nomograms in oncology: more than meets the eye","volume":"16","author":"Balachandran","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00259-019-04505-2","article-title":"Prediction nomogram for (68) Ga-Psma-11 PET\/CT in different clinical settings of PSA failure after radical treatment for prostate cancer","volume":"47","author":"Ceci","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1093\/rheumatology\/keab818","article-title":"One-year renal outcome in lupus nephritis patients with acute kidney injury: a nomogram model","volume":"61","author":"Sun","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ajem.2016.10.013","article-title":"Effects of age on the outcome of peritoneal dialysis-associated peritonitis","volume":"35","author":"Wang","year":"2017","journal-title":"Am J Emerg Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/0886022x.2020.1786401","article-title":"Red blood cell distribution width and peritoneal dialysis-associated peritonitis prognosis","volume":"42","author":"He","year":"2020","journal-title":"Ren Fail"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"639744","DOI":"10.3389\/fmed.2021.639744","article-title":"Novel predictors and risk score of treatment failure in peritoneal dialysis-related peritonitis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0225316","DOI":"10.1371\/journal.pone.0225316","article-title":"Effect of diabetes on incidence of peritoneal dialysis-associated peritonitis","volume":"14","author":"Ueda","year":"2019","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/0886022x.2020.1783680","article-title":"Serum C-reactive protein to albumin ratio and mortality associated with peritoneal dialysis","volume":"42","author":"Liu","year":"2020","journal-title":"Ren Fail"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/089686080902900313","article-title":"Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area","volume":"29","author":"Afolalu","year":"2009","journal-title":"Perit Dial Int"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12882-017-0588-4","article-title":"The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients","volume":"18","author":"Ye","year":"2017","journal-title":"BMC Nephrol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1053\/j.ajkd.2014.02.025","article-title":"Peritoneal Dialysis-related peritonitis: towards improving evidence, practices, and outcomes","volume":"64","author":"Cho","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4103\/1319-2442.284006","article-title":"Low serum albumin a predictor sign of the incidence of peritoneal Dialysis-associated peritonitis? A quasi-systematic review","volume":"31","author":"Alharbi","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/ijgm.S102819","article-title":"Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements","volume":"9","author":"Levitt","year":"2016","journal-title":"Int J Gen Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e0190410","DOI":"10.1371\/journal.pone.0190410","article-title":"The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease","volume":"13","author":"Alves","year":"2018","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/cjn.13121215","article-title":"Inflammation and progression of CKD: the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref29","first-page":"55","article-title":"Hypoalbuminemia in peritoneal Dialysis patients","volume":"29","author":"Guest","year":"2013","journal-title":"Adv Perit Dial"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000350150","article-title":"The association between peritoneal charge barrier dysfunction and protein lost during continuous ambulatory peritoneal Dialysis","volume":"37","author":"Yu","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1053\/ajkd.2003.50128","article-title":"Albumin at the start of peritoneal dialysis predicts the development of peritonitis","volume":"41","author":"Wang","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2215\/cjn.00830116","article-title":"Peritonitis before peritoneal dialysis training: analysis of causative organisms, clinical outcomes, risk factors, and long-term consequences","volume":"11","author":"Ma","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5301\/jn.5000169","article-title":"Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis","volume":"26","author":"Zhang","year":"2013","journal-title":"J Nephrol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.krcp.2016.06.002","article-title":"Low prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis","volume":"35","author":"Lee","year":"2016","journal-title":"Kidney Res Clin Pract"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"14977","DOI":"10.1038\/s41598-018-33361-7","article-title":"Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: a retrospective analysis","volume":"8","author":"Oh","year":"2018","journal-title":"Sci Rep"},{"key":"ref36","first-page":"217","article-title":"Inflammation, left ventricular hypertrophy, and mortality in end-stage renal disease","volume":"10","author":"Cafka","year":"2016","journal-title":"Iran J Kidney Dis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e007876","DOI":"10.1161\/jaha.117.007876","article-title":"High-sensitivity troponin T and C-reactive protein have different prognostic values in hemo- and peritoneal dialysis populations: a cohort study","volume":"7","author":"Chen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.clnu.2017.08.013","article-title":"An inflammation-based prognostic score, the C-reactive protein\/albumin ratio predicts the morbidity and mortality of patients on parenteral nutrition","volume":"37","author":"Llop-Talaveron","year":"2018","journal-title":"Clin Nutr"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s12882-020-02174-0","article-title":"Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in non-dialysis patients with end-stage renal disease (ESRD)","volume":"21","author":"Li","year":"2020","journal-title":"BMC Nephrol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12967-019-1808-4","article-title":"Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese cohort study of chronic kidney disease (C-Stride)","volume":"17","author":"Yuan","year":"2019","journal-title":"J Transl Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000484177","article-title":"Lymphocyte cell ratios and mortality among incident hemodialysis patients","volume":"46","author":"Catabay","year":"2017","journal-title":"Am J Nephrol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e001918","DOI":"10.1161\/jaha.115.001918","article-title":"Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies","volume":"4","author":"Hung","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","article-title":"Malnutrition-inflammation complex syndrome in Dialysis patients: causes and consequences","volume":"42","author":"Kalantar-Zadeh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.21037\/jgo-22-683","article-title":"The prognostic role of neutrophil-to-lymphocyte ratio and C-reactive protein in metastatic colorectal cancer using regorafenib: a systematic review and meta-analysis","volume":"13","author":"Zhao","year":"2022","journal-title":"J Gastrointest Oncol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/0886022x.2012.734429","article-title":"Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease","volume":"35","author":"Okyay","year":"2013","journal-title":"Ren Fail"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000488696","article-title":"High neutrophil-to-lymphocyte ratio is a significant predictor of cardiovascular and all-cause mortality in patients undergoing peritoneal dialysis","volume":"43","author":"Lu","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.3390\/ijms21114066","article-title":"Hyperuricemia and hypertension, coronary artery disease, kidney disease: from concept to practice","volume":"21","author":"Gaubert","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12882-020-01800-1","article-title":"Roles of peritoneal clearance and residual kidney removal in control of uric acid in patients on peritoneal Dialysis","volume":"21","author":"Xiao","year":"2020","journal-title":"BMC Nephrol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"751182","DOI":"10.3389\/fcvm.2021.751182","article-title":"Serum uric acid and cardiovascular or all-cause mortality in peritoneal dialysis patients: a systematic review and meta-analysis","volume":"8","author":"Liu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"F993","DOI":"10.1152\/ajprenal.00637.2014","article-title":"Hyperuricemia-induced Nlrp3 activation of macrophages contributes to the progression of diabetic nephropathy","volume":"308","author":"Kim","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3892\/ijmm.2015.2148","article-title":"Soluble uric acid increases NALP3 inflammasome and interleukin-1\u03b2 expression in human primary renal proximal tubule epithelial cells through the Toll-like receptor 4-mediated pathway","volume":"35","author":"XIAO","year":"2015","journal-title":"Int J Mol Med"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/nep.12613","article-title":"U-shaped relationship between uric acid and residual renal function decline in continuous ambulatory peritoneal Dialysis patients","volume":"22","author":"Hsieh","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/0886022x.2020.1761387","article-title":"A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal Dialysis patients","volume":"42","author":"Yang","year":"2020","journal-title":"Ren Fail"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000484284","article-title":"Uric acid and diabetic nephropathy risk","volume":"192","author":"Mauer","year":"2018","journal-title":"Contrib Nephrol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/cjn.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.ajkd.2019.08.005","article-title":"Dialysis care and dialysis funding in Asia","volume":"75","author":"Tang","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"3021785","DOI":"10.1155\/2019\/3021785","article-title":"The protective role of adiponectin for lipoproteins in end-stage renal disease patients: relationship with diabetes and body mass index","volume":"2019","author":"Coimbra","year":"2019","journal-title":"Oxidative Med Cell Longev"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/diacare.26.2.510","article-title":"Quantifying the risk of infectious diseases for people with diabetes","volume":"26","author":"Shah","year":"2003","journal-title":"Diabetes Care"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"e3446","DOI":"10.1002\/dmrr.3446","article-title":"High-sensitivity C-reactive protein and risk of type 2 diabetes: a nationwide cohort study and updated meta-analysis","volume":"37","author":"Yang","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e2523","DOI":"10.1210\/clinem\/dgac074","article-title":"C-reactive protein and racial differences in type 2 diabetes incidence: the regards study","volume":"107","author":"Peper","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.2215\/cjn.11431210","article-title":"Geographic and educational factors and risk of the first peritonitis episode in Brazilian peritoneal dialysis study (BRAZPD) patients","volume":"6","author":"Martin","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2215\/cjn.00910209","article-title":"Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database","volume":"4","author":"Nessim","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1089\/sur.2012.195","article-title":"Effects of age and diabetes mellitus on clinical outcomes in patients with peritoneal dialysis-related peritonitis","volume":"14","author":"Tsai","year":"2013","journal-title":"Surg Infect"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10157-013-0872-y","article-title":"A 10-year retrospective cohort study on the risk factors for peritoneal dialysis-related peritonitis: a single-center study at Tokai University Hospital","volume":"18","author":"Nishina","year":"2014","journal-title":"Clin Exp Nephrol"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4239\/wjd.v11.i10.435","article-title":"Comparison of clinical features and outcomes in peritoneal dialysis-associated peritonitis patients with and without diabetes: a multicenter retrospective cohort study","volume":"11","author":"Meng","year":"2020","journal-title":"World J Diabetes"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1193754\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:28:08Z","timestamp":1694770088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1193754\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":66,"alternative-id":["10.3389\/fmed.2023.1193754"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1193754","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"article-number":"1193754"}}